DSN, higi introduce first-ever Fit Pharmacist Challenge

Drug Store News, in partnership with higi, is hosting the first-ever Fit Pharmacist Challenge, a series of fitness-tracking competitions that will reward winning pharmacists and pharmacy technicians. Read more ...

NACDS, U.S. Pain Foundation discuss Rx abuse, access in joint op-ed

The complex issues of prescription drug abuse and access are not receiving the comprehensive approach that they deserve and greater collaboration is needed among all stakeholders to help find solutions. Read More ...

Surescripts handled more transactions than Amex or PayPal in 2014

Surescripts processed 6.5 billion health-data transactions in 2014. Read More ...

PQA creates three measures to help track opioid prescriptions

The membership of the Pharmacy Quality Alliance has endorsed three new performance measures that assess the use of opioids from multiple providers or at high dosage in persons without cancer. Read More ...

Current news

Your phone can tell you the weather, the latest stock reports, sync your email and send you calendar reminders, and now with Fertility Friend, women can use their phones to monitor ovulation cycles.
Pharmacists caring for underserved patients with suboptimally controlled type 2 diabetes were more adherent to their medications and had better glycemic control than those who did not have a pharmacist in their care team, according to a recent report.
Recognizing that onsite health facilities can be an integral component of a successful health care program, employers are seeking to expand their use of such centers in the coming years, according to new research by global professional services company Towers Watson.
The Food and Drug Administration Friday announced that it had approved Rapamune (sirolimus), distributed by Pfizer’s Wyeth Pharmaceuticals, as a treatment for the rare lung disease lymphangioleiomyomatosis (LAM).
Teva on Friday announced that it would be rolling out Junel Fe 24, a generic version of Lomedia 24 Fe birth control bills.
On Thursday Roxane Laboratories announced that its alosetron hydrochloride tablets — a generic version of irritable bowel syndrome treatment Lotronex — was available in 0.5- and 1-mg strength.
Fruth Pharmacy has unveiled new technology to make prescription label reading easier for the visually impaired by partnering with AccessaMed to bring a special prescription label into all 26 Fruth Pharmacy locations.
Some online pharmacy sites will soon be able to point visitors to their .pharmacy domain names.
Camber Pharmaceuticals on Thursday announced that it had launched antipsychotic drug aripiprazole — a generic version of Abilify — in 2-, 5-, 10-, 15-, 20- and 30-mg strength tablets.
One on Thursday announced the launch of Vanish Hyperthin condoms.

CPE Monitor Reminders

As of May 1, 2014, ACPE-accredited CE Providers, such as Drug Store News, may no longer issue statements of credit. All credit awarded by ACPE-accredited providers to pharmacists and pharmacy technicians must be via CPE Monitor. Any statements obtained from the Drug Store News website are no longer valid statements of credit. You MUST obtain your statement of credit from CPE Monitor at MyCPEMonitor.net.

Please be sure that you enter your correct NABP e-PID number in your Drug Store News CE profile. This ensures your CE credit will be transmitted to CPE Monitor so you may receive credit for completed CPE activities. To look up your e-PID number go to the MyCPEMonitor.net or NABP.net site and search the system for their NABP e-PID number.